Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Microfactory SAS currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This active matter is assigned to 1 distinct examiner and 1 distinct art unit. The data indicates that the company's current patent prosecution is concentrated in this single technical field, with no other active matters reported.
BRAZIN, JACQUELINE is the busiest examiner for the company, currently overseeing 1 pending office action. The presence of 1 distinct art unit shows that the company's biotechnology is being evaluated by a single specialized division. This individual handles the 1 pending office action for the portfolio.
For a practitioner, this concentration means that the prosecution strategy is focused on the 1 distinct examiner. There are no other active cases or different art units to coordinate, allowing for a direct approach. The company's immediate goals in Biotechnology & Pharmaceuticals are tied to the outcome of this single matter, making the interaction with the assigned examiner a primary focus.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BRAZIN, JACQUELINE | 1 | 65.6% | +52.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18260899 | ANALYSIS OF CELLS AND/OR ORGANELLES IN HYDROGEL CAGES | BRAZIN, JACQUELINE | — |
| Art Unit | Apps |
|---|---|
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18260899 | ANALYSIS OF CELLS AND/OR ORGANELLES IN HYDROGEL CAGES | BRAZIN, JACQUELINE | 1682 | §103 | Non-Final OA | — | Pending | Jul 10, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMicrofactory SAS has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Jacqueline Brazin has the most, with 1 of Microfactory SAS's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.